The university will hire 10 faculty members and team with the state and major health systems on what it calls a comprehensive plan to understand and deal with addictions, which are costing Indiana more than $1 billion a year.
California has passed a law requiring pharmaceutical companies to explain their price increases, escalating the state-by-state battle between lawmakers trying to bring more transparency to the industry’s practices and drugmakers that oppose the efforts.
The White House is finalizing an executive order that would expand health plans offered by associations to allow individuals to pool together and buy insurance outside their states.
Harry Zhang pleaded guilty to two felonies this month after charged with illegally obtaining prescriptions from Canada and Germany and reselling them in China.
Thirty-four new drugs—treating everything from cancer to rare genetic diseases—have been approved so far this year. That’s on pace to nearly double last year’s approvals.
High-deductible health plans are booming in popularity, but, in an effort to save money, too many people are skipping preventive care even though such visits are covered 100 percent.
The city of Indianapolis plans to file a “robust lawsuit” against several drug companies, Mayor Joe Hogsett announced Thursday morning.
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
From January to July, the agency sent 265 warning letters to companies, notifying them of what it alleged to be serious violations of federal rules. That’s the lowest tally for the first seven months of any year since 2008.
Castlight Health, a benefits platform, estimates that opioid abusers cost employers nearly twice as much in health-care expenses as their clean co-workers—an extra $8,600 a year.
Unfortunately, what started as a solution for pain turned into a crisis that is killing people.
A sampling of panelists’ conversation at IBJ’s Sept. 21 Health Care & Benefits Power Breakfast.
Hoosiers buying health insurance on the Obamacare marketplace will pay an average of nearly $500 a month in premiums next year, a sharp rise over current rates.
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
Senate Republicans, short of votes, abandoned their latest and possibly final attempt to kill the health care law Tuesday, just ahead of a critical end-of-the-week deadline.
Roger Werner played a “central role” in helping fellow executives fleece the nursing home company, according to a new federal lawsuit.
Health experts at an IBJ Health Care & Benefits panel discussion on Thursday said passage of the Graham-Cassidy bill could challenge Indiana's ability to care for low-income Hoosiers.
Indiana Gov. Eric Holcomb has joined 14 other Republican governors in backing a last-ditch GOP effort to repeal former President Barack Obama's signature health care law.
The deal for HealthSun gives Anthem another 40,000 members and helps build its base in south Florida.
